暴露和子宫内生长限制之间的关联:系统性审查和元分析
Jing Jiang1,2, Xuan Zuo1,2, Songlin An1,3
1School of Public Health, Zunyi Medical University, Zunyi, China.
PloS one
|June 2, 2025
概括
暴露与妊娠年龄 (SGA) 较小的出生风险增加有关,特别是在亚洲. 公共卫生政策的目标应该是减少孕妇在怀孕期间接触的风险.
科学领域:
- 环境健康 环境健康
- 生殖流行病学 生殖流行病学
- 毒理学 毒理学 毒理学
背景情况:
- 观察性研究表明 (As) 暴露与子宫内生长限制 (IUGR) 之间存在联系,但研究结果不一致.
- 流行病学数据的异质性需要对As-IUGR关联进行系统的评估.
研究的目的:
- 系统地评估暴露与子宫内生长限制 (IUGR) 结果之间的关联,包括怀孕年龄相对小 (SGA),早产 (PTB) 和低出生体重 (LBW).
- 确定异质性的来源,并评估检查暴露和IUGR的研究中的出版偏见.
主要方法:
- 对11项涉及2,183,652名参与者的研究进行了元分析,搜索了6个数据库,截至2024年5月.
- 使用NOS,AHRQ和NTP/OHAT工具评估了偏见风险. 随机效应或固定效应模型被用于元分析.
- 用子组,元回归,Egger,Begg测试和漏斗图来分析异质性和出版偏差.
主要成果:
- 在暴露和SGA之间发现了显著的关联 (OR:1.06,95%CI:1.00,1.13),特别是在亚洲 (OR:1.28,95%CI:1.10,1.49).
- 母亲暴露于更高的水平 (10-100μg/L) 与SGA显著相关 (OR:1.25,95% CI:1.04,1.50).
- 特定的暴露水平与增加的PTB (1-10μg/L) 和LBW (0-1μg/L) 风险有关,尽管整体关联并不显著.
结论:
- 暴露与IUGR的风险增加有关,主要是SGA.
- 小组分析表明,特定的暴露水平会增加PTB和LBW风险.
- 这些发现强调需要采取更严格的公共卫生政策,以减轻怀孕期间的暴露,同时承认潜在的异质性和出版偏见.
相关概念视频
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Genome-wide Association Studies-GWAS
14.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.4K


